Discover how a single daily pill is transforming hypertension treatment. Simplified care and better results are reshaping patient health globally.

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...

On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...

As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

Adequate Sleep Significantly Reduces the Risk of Hypertension in Adolescents Nov. 11, 2024 — Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to ...

Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

Both sleep and physical activity are modifiable lifestyle factors that have the potential to reduce hypertension risk among ...

In this study, gestational hypertension, preeclampsia, and eclampsia were associated with an increased risk of new-onset migraine, headache, epilepsy, sleep disorder, or mental fatigue within months ...

Out of 1.66 crore people aged 30 and above in Telangana, 22.94 lakh suffer from hypertension, while 11.9 lakh have diabetes, ...